Nanochon

Nanochon is developing a low cost and highly effective device to treat cartilage damage in the knee, in young and active patients, based on 3D printing and a synthetic cartilage like polymer.

Nanochon is a company in health based in Tokyo, Japan.

Profile

Nanochon is a biotechnology company producing a novel 3D printed material that replaces lost and damaged cartilage and encourages new tissue growth to treat joint-related issues due to injuries and osteoarthritis. This material will increase the accessibility of treating knee damage and improve outcomes by temporarily replacing cartilage while encouraging the regrowth of natural cartilage.

Nanochon is positioned in health, a segment that rewards a clear, focused offering.

Its base of operations is Tokyo, Japan.

Directory data places it at the SBIR Phase I stage.

It has disclosed roughly $225K in funding.

Website: www.nanochon.com